Literature DB >> 16259773

Dexmedetomidine prolongs spinal anaesthesia induced by levobupivacaine 0.5% in guinea-pigs.

Jorge A Calasans-Maia1, Gisele Zapata-Sudo, Roberto T Sudo.   

Abstract

Alpha-2 adrenoceptor agonists have been used in association with local anaesthetic to increase the duration of spinal anaesthesia. Intrathecal administration of clonidine prolonged motor blockade induced by local anaesthetic. Since the affinity of dexmedetomidine (DEX) to alpha-2 adrenoceptors is eight-times greater than clonidine, it is expected that DEX could be advantageous in clinical anaesthesia. We investigated the duration of motor nerve block induced by spinal injection of 0.5% levobupivacaine (LVB) associated with intrathecal or intraperitoneal administration of DEX. Seventy-two guinea-pigs were randomly divided in 12 groups, which were all treated with intrathecal injection of 50 microL of LVB. DEX was injected intrathecally with LVB in 6 groups or injected intraperitoneally after LVB in another 6 groups. Intrathecal DEX (0.1, 0.2 and 0.4 microg) increased the LVB-induced motor anaesthesia from 48 (41-66) min to 84.5 (52-91) min (P < 0.05), 101.5 (83-115) min (P < 0.05) and 105 (97-114) min (P < 0.05), respectively. Similarly, intraperitoneal DEX (20 and 40 microg kg(-1)) increased the motor blockade from 48.5 (33-59) min to 88 (71-114) min (P < 0.05) and 114.5 (103-156) min (P < 0.05), respectively. Pre-treatment with yohimbine reduced the duration of motor block from 101.5 (83-115) to 76.5 (68-86) min (P < 0.05) or from 114.5 (103-156) to 90 (83-93) min (P < 0.05) when DEX was administered by the intrathecal or intraperitoneal routes. Motor block induced by spinal injection of LVB was prolonged by intrathecal and systemic administration of DEX, which was partially dependent on activation of alpha-2 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259773     DOI: 10.1211/jpp.57.11.0006

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  The effects of 2 µg and 4 µg doses of dexmedetomidine in combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its postoperative analgesic characteristics.

Authors:  Abdulkadir Yektaş; Enver Belli
Journal:  Pain Res Manag       Date:  2014-02-13       Impact factor: 3.037

Review 3.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  A Comparative Study Evaluating the Efficacy of Lignocaine and Dexmedetomidine with Lignocaine and Adrenaline in Third Molar Surgery.

Authors:  Thomson Mariadasan Dcruz; Charmiben Patel; Abhijeet Masih; Izaz Shaik
Journal:  J Maxillofac Oral Surg       Date:  2020-11-09

5.  Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.

Authors:  Divya Bhansali; Shavonne L Teng; Caleb S Lee; Brian L Schmidt; Nigel W Bunnett; Kam W Leong
Journal:  Nano Today       Date:  2021-06-19       Impact factor: 18.962

6.  The effects of dexmedetomidine added to spinal levobupivacaine for transurethral endoscopic surgery.

Authors:  Aliye Esmaoğlu; Sümeyra Türk; Adnan Bayram; Aynur Akın; Fatih Uğur; Ayşe Ulgey
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

7.  Comparison of Intravenous Dexmedetomidine with Midazolam in Prolonging Spinal Anaesthesia with Ropivacaine.

Authors:  Balwinder Kaur Rekhi; Tejinderpal Kaur; Divya Arora; Pankaj Dugg
Journal:  J Clin Diagn Res       Date:  2017-02-01

8.  The effects of single-dose intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia.

Authors:  Seung Hwan Jung; Soo Kyung Lee; Kyung Jee Lim; Eun Young Park; Mae Hwa Kang; Jung Min Lee; Jae Jun Lee; Sung Mi Hwang; Sung Jun Hong
Journal:  J Anesth       Date:  2013-01-10       Impact factor: 2.078

9.  Neurotoxicity of intrathecal injections of dexmedetomidine into the rat spinal dorsal horn.

Authors:  Jiabao Hou; Zhongyuan Xia; Xingpeng Xiao; Xing Wan; Bo Zhao
Journal:  Neural Regen Res       Date:  2012-08-15       Impact factor: 5.135

10.  Effects of intrathecal dexmedetomidine as an additive to low-dose bupivacaine in patients undergoing transurethral resection of prostate.

Authors:  Ipsita Chattopadhyay; Sumantra Sarathi Banerjee; Amarendra Kumar Jha; Srabani Basu
Journal:  Indian J Anaesth       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.